Teoxane to Present babyGLOW™ at IMCAS 2026

At IMCAS 2026, Teoxane will present its latest scientific developments, including the babyGLOW™ injection technique and innovations in dynamic lip treatments with the RHA® Kiss Collection. The company’s presence will include three scientific posters and a dedicated symposium, providing healthcare professionals with insight into emerging techniques and evidence-based protocols.

Teoxane babyGLOW™: Technique-Driven Skin Quality

babyGLOW™ is a standardized, anatomy-based injection technique using eight targeted facial points designed to optimize product distribution and enhance skin radiance. The procedure employs TEOSYAL® Puresense Redensity 1, a non-crosslinked hyaluronic acid with a Dermostructuring Complex, for uniform dermal and subdermal integration.

At IMCAS, Teoxane will present two posters detailing the development and clinical evaluation of babyGLOW™, including assessments using standardized photography, patient-reported outcomes, ultrasound, and 3D volumetric imaging. Results indicate high practitioner and patient satisfaction, with reported improvements in skin radiance and overall quality.

RHA® Kiss Collection: Dynamic Lip Injection Techniques

Teoxane will also present a poster on dynamic lip injection techniques, introducing a structured clinical classification to support safer and more consistent decision-making. The poster highlights a new Bi-directional injection technique, designed for beginner practitioners, adaptable to various aesthetic goals, and characterized by a low vascular risk profile.

The presentation emphasizes the use of hyaluronic acid fillers, such as the RHA® Kiss Collection, engineered to maintain natural lip expression and movement. Supporting materials include peer-reviewed publications and a new Continuing Medical Education (CME) module.

Scientific Symposium and Expert Education

Teoxane’s symposium will take place on Thursday, 29th January 2026, from 13:30–15:30 at Amphi Bleu (Level 2), moderated by Dr. Raul Cetto (UK). The program includes:

Part I: Teoxane babyGLOW™

• Lecture: Understanding Skin Quality, Patient Needs, and Trends

• Case Study: Improving Skin Quality in Female and Male Patients
  Presented by Dr. Kieren Bong (UK), Dr. Silvia Caboni (Italy), Prof. Wioletta Baranska Rybak (Poland)

Part II: RHA® Kiss Collection

• Lecture: Understanding Lip Beauty, Patient Needs, and Trends

• Case Studies: Dynamic Beautification and Rejuvenation
  Presented by Dr. Raul Cetto (UK), Dr. Bilur Sezgin (Turkey)

Mounia Heddad-Masson, Director of Global Medical Education & Medical Affairs at Teoxane, commented:
"Medical education is at the core of Teoxane’s scientific mission. Teoxane babyGLOW™ is a clear expression of this approach. The technique was developed with input from over 20 expert injectors across six countries and refined through real-world practice. IMCAS provides an opportunity to present this technique to the international community within a robust scientific and educational framework."

Complementary In-Clinic and At-Home Skin Quality

Teoxane will also showcase its Aesthetic Skincare portfolio, which complements in-clinic treatments and supports clinical outcomes between sessions. Products include the Teoxane Hydra Mask and RHA® Serum, both designed to support skin quality and recovery using Teoxane’s hyaluronic acid expertise.

Healthcare professionals can visit booth L206 (Level 2) during IMCAS 2026 to learn about these scientific contributions, educational programs, and the latest clinical innovations.